Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pathology, Research and Practice

• Publication date

  2007-12-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.PRP.2007.08.006PMID 17913382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.

  2006cited by this paper
• Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.

  2006cited by this paper
• Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.

  2006cited by this paper
• Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.

  2006cited by this paper
• Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.

  2005cited by this paper
• nNOS Gene Deletion Exacerbates Pathological Left Ventricular Remodeling and Functional Deterioration After Myocardial Infarction

  2005cited by this paper
• Integrin stimulation induces calcium signalling in rat cardiomyocytes by a NO-dependent mechanism

  2005cited by this paper
• Peroxynitrite‐mediated matrix metalloproteinase‐2 activation in human hepatic stellate cells

  2005cited by this paper
• Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure.

  2005influential reference
• Role of Myocardial Neuronal Nitric Oxide Synthase–Derived Nitric Oxide in &bgr;-Adrenergic Hyporesponsiveness After Myocardial Infarction–Induced Heart Failure in Rat

  2004cited by this paper
• Increased neuronal nitric oxide synthase-derived NO production in the failing human heart.

  2004cited by this paper
• S-nitrosylation: a potential new paradigm in signal transduction.

  2004cited by this paper
• Up‐regulation of cardiac nitric oxide synthase 1‐derived nitric oxide after myocardial infarction in senescent rats

  2003cited by this paper
• Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

  2003influential reference
• Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.

  2002cited by this paper
• Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms

  2002cited by this paper
• PYK 2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy

  2002cited by this paper
• PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy.

  2002cited by this paper
• Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• Integrins and the myocardium.

  2001cited by this paper
• Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes

  2001cited by this paper
• Integrins and the myocardium.

  2001cited by this paper
• Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor

  2000cited by this paper
• Alterations of endothelium and smooth muscle function in monocrotaline-induced pulmonary hypertensive arteries.

  2000cited by this paper
• Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts

  2000cited by this paper
• Integrin Activation and Focal Complex Formation in Cardiac Hypertrophy*

  2000cited by this paper
• Infarct size and nitric oxide synthase in murine myocardium.

  2000cited by this paper
• Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.

  1998cited by this paper
• Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

  1998cited by this paper
• Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts.

  1998cited by this paper
• Role of integrins in cellular responses to mechanical stress and adhesion.

  1997cited by this paper
• Nitric oxide activates skeletal and cardiac ryanodine receptors.

  1997cited by this paper
• Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.

  1996cited by this paper
• Mechanisms of integrin-mediated calcium signaling in MDCK cells: regulation of adhesion by IP3- and store-independent calcium influx.

  1996cited by this paper
• Proteolytic remodeling of extracellular matrix.

  1995cited by this paper
• Mechanisms and pathology of monocrotaline pulmonary toxicity.

  1992cited by this paper
• Right ventricular performance after monocrotaline-induced pulmonary hypertension.

  1989cited by this paper
• Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.

  1988cited by this paper
• Changes in pulmonary structure and function induced by monocrotaline intoxication.

  1981cited by this paper
• Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats.

  1974cited by this paper

• Crocin's role in modulating MMP2/TIMP1 and mitigating hypoxia-induced pulmonary hypertension in mice

  2024cites this paper
• Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight

  2024influential citation
• Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

  2021cites this paper
• Animal models of pulmonary hypertension: Getting to the heart of the problem

  2021cites this paper
• Experimental Models

  2021cites this paper
• Rosiglitazone Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Regulating the Extracellular Matrix Remodelling

  2020cites this paper
• Magnesium lithospermate B improves pulmonary artery banding induced right ventricular dysfunction by alleviating inflammation via p38MAPK pathway.

  2020cites this paper
• Hypertension-induced changes in the rat myocardium during the development of cardiac hypertrophy - a comparison between the left and the right ventricle.

  2019cites this paper
• Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity

  2019cites this paper
• Right heart in pulmonary hypertension: from adaptation to failure

  2019cites this paper
• Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension

  2017cites this paper
• Remodeling of ventricular repolarization in experimental right ventricular hypertrophy.

  2017cites this paper
• Physiopathology of Pulmonary Hypertension: from Bio-Molecular Mechanism to Target Treatment

  2016cites this paper
• Neuronal nitric oxide synthase in hypertension – an update

  2016cites this paper
• Adaptive capacity of the right ventricle: why does it fail?

  2015influential citation
• Aberrant gene expression of heparanase in ventricular hypertrophy induced by monocrotaline in rats

  2015cites this paper
• Genes Mediating Cardiac Remodeling During Pregnancy and the Early Post-Partum-Period in Mice

  2014cites this paper
• Translational research in pulmonary hypertension: challenge and opportunity

  2014cites this paper
• ErbB/integrin signaling interactions in regulation of myocardial cell-cell and cell-matrix interactions.

  2013cites this paper
• Targeting cell motility in pulmonary arterial hypertension

  2013cites this paper
• Reactive oxygen species as therapeutic targets in pulmonary hypertension

  2013cites this paper
• Novel Therapeutic Approaches to Preserve the Right Ventricle

  2013cites this paper
• Adverse biventricular remodeling in isolated right ventricular hypertension is mediated by increased transforming growth factor-β1 signaling and is abrogated by angiotensin receptor blockade.

  2013cites this paper
• Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.

  2012cites this paper
• Hypertension pulmonaire : de la physiopathologie moléculaire aux anomalies hémodynamiques

  2012cites this paper
• [Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].

  2012cites this paper
• New frontiers in heart hypertrophy during pregnancy.

  2012cites this paper
• Review Article New frontiers in heart hypertrophy during pregnancy

  2012cites this paper
• Mechanisms of disease: pulmonary arterial hypertension

  2011cites this paper
• Implication de la voie de signalisation Src/Stat3 dans l'étiologie de l'hypertension artérielle pulmonaire

  2011cites this paper
• Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice

  2011cites this paper
• Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment

  2011cites this paper
• Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: The MESA-RV Study

  2010cites this paper
• Review Articles Right Ventricular Heart Failure From Pulmonary Embolism: Key Distinctions From Chronic Pulmonary Hypertension

  2010cites this paper
• Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension.

  2010cites this paper
• Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.

  2010cites this paper
• Pressure Overload-induced Right Ventricular Failure is Associated with Re-expression of Myocardial Tenascin-C and Elevated Plasma Tenascin-C Levels

  2009cites this paper
• Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.

  2009cites this paper
• Molecular and cellular characterization of cardiac overload-induced hypertrophy and failure

  2009cites this paper
• Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart

  2009cites this paper
• Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats.

  2008cites this paper
• A Clinically Applicable Scaffold for Cardiac Regeneration

  2008cites this paper